Intercept Pharmaceuticals, Inc.
USD19.00
+0.04 (+0.21%)
CEO
Jerome B. Durso
IPO Date
2012-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.00
Prev. Close
$18.96
Day Low
$18.98
Day High
$19.01
52W Low
$8.82
52W High
$21.86
Market Cap
$0.79B
Volume
3.91M
| -3.6 |
| 31 Dec 2020 | FY | 98.3% | -103.7% | 194.3% | -55.9% | -3.45 | 2.66 | -2.5 |
| 31 Dec 2019 | FY | 98.3% | -155.2% | -758.5% | -51.8% | 10.45 | 4.45 | -10.0 |
| 31 Dec 2018 | FY | 98.6% | -172.0% | -1616.5% | -60.7% | 19.41 | 4.22 | -9.3 |
| 31 Dec 2017 | FY | 99.0% | -275.2% | -2199.2% | -74.4% | 21.71 | 4.31 | -4.1 |
| 31 Dec 2016 | FY | 100.0% | -1654.6% | -131.1% | -55.8% | 1.08 | 9.02 | -6.5 |
| 31 Dec 2015 | FY | 100.0% | -8139.1% | -37.6% | -34.5% | 0.00 | 13.55 | -15.6 |
| 31 Dec 2014 | FY | 100.0% | -16258.7% | -122.7% | -111.4% | 0.00 | 16.13 | -11.4 |
| 31 Dec 2013 | FY | 100.0% | -4180.5% | -82.3% | -45.1% | 0.00 | 16.61 | -18.2 |
| -19.7 |
| 31 Mar 2023 | Q1 | 99.7% | -43.5% | -44.0% | -5.9% | 4.96 | 2.37 | -4.7 |
| 31 Dec 2022 | Q4 | 100.0% | -26.4% | -21.9% | -3.7% | 3.57 | 2.35 | -6.3 |
| 30 Sept 2022 | Q3 | 99.5% | 223.6% | 161.1% | 31.0% | 3.09 | 2.46 | 0.7 |
| 30 Jun 2022 | Q2 | 99.6% | -10.5% | 2.0% | -1.5% | -1.93 | 3.22 | -13.6 |
| 31 Mar 2022 | Q1 | 99.1% | -19.5% | 4.6% | -3.4% | -1.95 | 3.16 | -7.0 |
| 31 Dec 2021 | Q4 | 98.9% | -39.3% | 19.7% | -6.9% | -2.97 | 3.01 | -3.3 |
| 30 Sept 2021 | Q3 | 99.3% | -3.9% | 2.3% | -0.7% | -3.46 | 3.45 | -32.4 |
| 30 Jun 2021 | Q2 | 99.4% | -11.5% | 5.5% | -2.1% | -2.89 | 3.39 | -14.9 |